Nouvelles

 

Le Département de génie biomédical de l’Université McGill vient de mettre sur pied un nouveau certificat qui donnera aux étudiants les outils nécessaires pour traduire les avancées de la recherche en génie biomédical en solutions cliniques et commerciales.
 
Le certificat comprend trois principaux cours :
1. Le brevetage de dispositifs médicaux
2. Les affaires réglementaires et systèmes de gestion de la qualité
3. La conception et réalisation d’essais cliniques.

Cliquer ici pour plus de détails sur le certificat ou encore visiter le site Web de l’Université McGill pour en savoir davantage.

Réseau thématique soutenu par le

 

Newsfeed

Stem Cells News -- ScienceDaily

Read about today's stem cell research including novel stem cell technology and advances in understanding cancer stem cells.
  • A first look at the earliest decisions that shape a human embryo
    For the first time, scientists have shown that a small cluster of cells in the human embryo dictates the fate of other embryonic cells. The discovery of this developmental 'organizer' could advance research into any human diseases, and it suggests we have more in common with birds than meets the eye.
  • Cause of pesticide exposure, Parkinson's link
    Previous studies have found an association between two commonly used agrochemicals (paraquat and maneb) and Parkinson's disease. Now a professor has determined that low-level exposure to the pesticides disrupts cells in a way that mimics the effects of mutations known to cause Parkinson's disease. Adding the effects of the chemicals to a predisposition for Parkinson's disease drastically increases the risk of disease onset.